1. Home
  2. ACT vs GKOS Comparison

ACT vs GKOS Comparison

Compare ACT & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACT
  • GKOS
  • Stock Information
  • Founded
  • ACT 1981
  • GKOS 1998
  • Country
  • ACT United States
  • GKOS United States
  • Employees
  • ACT N/A
  • GKOS N/A
  • Industry
  • ACT Specialty Insurers
  • GKOS Medical/Dental Instruments
  • Sector
  • ACT Finance
  • GKOS Health Care
  • Exchange
  • ACT Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • ACT 5.3B
  • GKOS 5.1B
  • IPO Year
  • ACT 2021
  • GKOS 2015
  • Fundamental
  • Price
  • ACT $36.13
  • GKOS $89.91
  • Analyst Decision
  • ACT Buy
  • GKOS Strong Buy
  • Analyst Count
  • ACT 4
  • GKOS 13
  • Target Price
  • ACT $37.75
  • GKOS $135.15
  • AVG Volume (30 Days)
  • ACT 796.2K
  • GKOS 1.1M
  • Earning Date
  • ACT 04-30-2025
  • GKOS 04-30-2025
  • Dividend Yield
  • ACT 2.05%
  • GKOS N/A
  • EPS Growth
  • ACT 9.98
  • GKOS N/A
  • EPS
  • ACT 4.44
  • GKOS N/A
  • Revenue
  • ACT $1,216,974,000.00
  • GKOS $404,523,000.00
  • Revenue This Year
  • ACT $3.68
  • GKOS $27.84
  • Revenue Next Year
  • ACT $4.25
  • GKOS $27.88
  • P/E Ratio
  • ACT $8.20
  • GKOS N/A
  • Revenue Growth
  • ACT 4.52
  • GKOS 23.92
  • 52 Week Low
  • ACT $29.37
  • GKOS $77.10
  • 52 Week High
  • ACT $37.56
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • ACT 55.56
  • GKOS 45.80
  • Support Level
  • ACT $35.31
  • GKOS $84.26
  • Resistance Level
  • ACT $36.95
  • GKOS $92.27
  • Average True Range (ATR)
  • ACT 0.87
  • GKOS 3.94
  • MACD
  • ACT 0.04
  • GKOS 0.57
  • Stochastic Oscillator
  • ACT 50.02
  • GKOS 58.87

About ACT Enact Holdings Inc.

Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The principal mortgage insurance customers are originators of residential mortgage loans who determine which mortgage insurer or insurers will be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: